Pharma Welcomes UK-Wide Applicability Of Revised Model Clinical Trials Agreement

The pharmaceutical industry has welcomed the UK's updated model clinical trials agreement that sponsors can now use to rapidly sign off contracts when undertaking clinical trials in hospitals run by the national health services throughout the country.

PS1803_Partner Handshake_425582335_1200.jpg
Industry, CROs Can Use The Agreement Without Modifications • Source: Shutterstock

The UK has issued updated templates of its "model clinical trials agreement" that pharmaceutical companies and contract research organizations can use, without modifications, for all industry-sponsored trials in National Health Service/Health and Social Care hospitals.

The revised templates are expected to speed-up the start of commercial trials in the UK as they will allow sponsors to sign off contracts more quickly so that trials can get underway

More from Clinical Trials

More from R&D